WXQ-16139-32152
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 208 / MD
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- 5ZC-25508-04127
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-06-22
Dose 1 — Pfizer-BioNTech
- 2022-06-22
- 2022-06-23
- 2022-06-25
- 2022-06-29
- 2022-07-06
-
2022-07-13
Dose 2 — Pfizer-BioNTech
- 2022-07-21
- 2022-07-27
-
2022-08-03
Survey response — day 21, dose 2, dependentMedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Runny, stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-12
- 2022-08-17
- 2022-08-26
- 2023-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Pfizer-BioNTech | No |
| 2 | 2022-07-13 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 2, dependent
Symptoms: Runny, stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release